14 DAY TRIAL // Good Technology’s quarterly device activation report for the first quarter of 2012 reveals that Apple's iPhone 4S hit a record high, securing the number one spot overall, with 37% of all activations - four times that of any other device.
The second place was nabbed by Apple’s iPad 2, with 17.7 percent of activations for the quarter, and the third by (you guessed it!) the fresh, third-generation iPad.
Barely one month out on the market, “the new iPad […] rocketed to the number four spot with 4.3 percent of all activations for the quarter, and an impressive 12.1 percent of activations in March alone,” according to the report (PDF).
John Herrema, Good Technology's SVP of corporate atrategy says companies are rapidly embracing the 'bring your own device' (BYOD) trend in the enterprise.
"BYOD smartphones and tablets combined with proactive, company-owned iPad deployments are driving rapid growth both the size and number of new deployments amongst our customers," says Herrema. "This includes significant growth in the number of Good users who have both a smartphone and a tablet, with the iPhone 4S and iPad 2 as the most frequently occurring combination."
Citing a Gartner study that forecast 118.9 million tablets sold this year, Good reports that iPads collectively represented an amazing 97.3 percent of all its tablet activations for this year’s first quarter.
This growth is reportedly driven by consumers and the overall BYOD trend, as well as by proactive enterprise deployment of tablet computers.
“Apple's iPhones and iPads remain the clear choice amongst end users when it comes to both BYOD and large company-driven deployments in verticals such as Financial Services, Business and Professional Services, Life Sciences and Healthcare,” reports Good Technology.
The highest rate of growth in the quarter for iPad net activations by industry was recorded in Life Sciences, “steadily increasing from less than three percent in October 2011 to nearly 14 percent in January 2012,” according to the report.
“This growth mirrors anecdotal data around proactive iPad deployments to sales forces in that industry, most notably among Pharmaceutical and Biotech companies,” Good Technology says.